List of companies in JLS Fund's investment portfolio

TRIPP is a digital wellness company that produces a VR meditation app.

Mushroom life sciences company focused on psychedelic medicines and nutraceutical products.

Gilgamesh Pharmaceuticals is a pharmaceutical platform company developing an oral arylcyclohexylamine therapeutic and the next generation of psychedelic-related medicines.

Wesana Health Holdings Inc is an emerging life sciences company championing the development and delivery of psychedelic and naturally-sourced therapies to treat traumatic brain injury. It is developing evidence-based formulations and protocols that empower patients to overcome neurological, psychological and mental health ailments caused by trauma.

Developer of a brain imaging technology designed to revolutionize neuropsychiatric healthcare. The company's technology helps to improve drug discovery and patient care, through its ability to sub-type and classify the human brain on a neurobiological level and offers therapeutic strategies to address psychiatric illness and central nervous system.

Developer of psilocybin-based medicines intended to treat disorders of the central nervous system. The company provides psychopharmacology, biotechnology, life sciences, neuropsychiatry, drug development, clinical trials, research, clinical drug development, psychopharmacology and psychedelic medicines.

Developer of a digital companion application designed for psychedelic therapy. The company's app encourages accountability and long-term change with personalized guides, tasks, and daily check-ins and gives preparation and integration support from a single, user-friendly platform that includes patient program content.

Fluence offers continuing education and certificate programs in psychedelic integration and psychedelic-assisted therapy.

Psychadelics

Awakn Life Sciences is a california-based company integrating psychedelics into psychotherapy founded in 2020 by Dr. Ben Sessa.